Category Archives: Pharmaceuticals

Healthcare stocks roar back after slump, while biotech IPOs continue stampede into pipeline.

The News: Rising healthcare stocks and fading qualms over an escalating Syrian conflict had Wall St. optimistic to start the week. Stocks had ended lower on Friday (April 13, 2018)… Read more »

Heath stock take it on the chin while immuno-oncology IPOs keep a coming.

1. Medical Stock Spotlight 1) Losers far outpaced winners last week with Edge Therapeutics Inc. (Nasdaq:EDGE) nosediving 93% over the week to $1.18. Up until last week, shares of Edge Thera… Read more »

Pharma shudders as study says placebo effect real and growing.

The News: Cancer survivors may be able to manage the extreme fatigue they experience after treatment by knowingly taking a placebo pill, according to researchers at University of Alabama at… Read more »

Immuno-oncology conundrum: Stage IV patient wants cutting-edge immunotherapy, but his oncologist says no. My personal take.

The News: Four women had an extremely rare, aggressive and fatal type of ovarian cancer. There was no standard treatment. All four women, who lived in different countries, asked their… Read more »

Biotech IPOs rock in 2018. More are storming into the queue.

Steve’s Take: Cutting-edge biotech startups and more established privately-funded but publicly held hopefuls are far and away the winners of the race for deep-pocket investors since New Year’s. I thought… Read more »

Warren Buffett’s bluster about new healthcare venture bound to backfire. Then what?

The News: Warren Buffett says his joint venture with Jeff Bezos and Jamie Dimon is going for something bigger than shaving a few percentage points off healthcare costs. The big… Read more »

South Korea’s Celltrion Inc. (Incheon) gets EU green light for Herceptin biosimilar

The News: Celltrion Inc. said on February 14, 2018 that it has received approval to sell its replica version of Roche Holding AG’s (Basel CHE) breast-cancer blockbuster Herceptin in Europe…. Read more »

Join a clinical trial? The success rate of such trials is higher than you thought, but still awfully low overall; especially for Alzheimer’s.

The News: Instead of less than 10% of drugs reaching the market, a new study has found that almost 15% of new compounds pass clinical trial–which still suggests that it’s… Read more »

Transpacific biotech Engine Biosciences raises $10 million in Southeast Asia’s largest life sciences seed round.

The News: Life sciences startups in Asia just got another shot in the arm with the $10 million investment in Engine Biosciences Pte. Ltd.–a biotech company that’s applying machine learning to… Read more »